Jeffrey Marx to Middle Aged
This is a "connection" page, showing publications Jeffrey Marx has written about Middle Aged.
Connection Strength
0.149
-
Ramsey DJ, Lazar DL, Blaha GR, Malott DL, Marx JL. Measuring Patient Loyalty in Ophthalmology: A Nationally Representative Study. Ophthalmology. 2018 07; 125(7):1124-1126.
Score: 0.043
-
Anderson C, Pahk P, Blaha GR, Spindel GP, Alster Y, Rafaeli O, Marx JL. Preferential Hyperacuity Perimetry to detect hydroxychloroquine retinal toxicity. Retina. 2009 Sep; 29(8):1188-92.
Score: 0.024
-
Pahk PJ, Todd DJ, Blaha GR, Soukiasian SH, Landmann DS, Craven DE, Tronic BS, Zabar Y, Marx JL. Intravascular lymphoma masquerading as Vogt-Koyanagi-Harada syndrome. Ocul Immunol Inflamm. 2008 May-Jun; 16(3):123-6.
Score: 0.022
-
Dhimitri KC, McGwin G, McNeal SF, Lee P, Morse PA, Patterson M, Wertz FD, Marx JL. Symptoms of musculoskeletal disorders in ophthalmologists. Am J Ophthalmol. 2005 Jan; 139(1):179-81.
Score: 0.017
-
Yepremyan M, Wertz FD, Tivnan T, Eversman L, Marx JL. Early treatment of cystoid macular edema secondary to branch retinal vein occlusion with intravitreal triamcinolone acetonide. Ophthalmic Surg Lasers Imaging. 2005 Jan-Feb; 36(1):30-6.
Score: 0.017
-
Marx JL, Hreib K, Choi IS, Tivnan T, Wertz FD. Percutaneous carotid artery angioplasty and stenting for ocular ischemic syndrome. Ophthalmology. 2004 Dec; 111(12):2284-91.
Score: 0.017
-
Boyer DS, Beer PM, Joffe L, Koester JM, Marx JL, Weisberger A, Yoser SL. Effect of adjunctive diclofenac with verteporfin therapy to treat choroidal neovascularization due to age-related macular degeneration: phase II study. Retina. 2007 Jul-Aug; 27(6):693-700.
Score: 0.005
-
Brown BA, Marx JL, Ward TP, Hollifield RD, Dick JS, Brozetti JJ, Howard RS, Thach AB. Homocysteine: a risk factor for retinal venous occlusive disease. Ophthalmology. 2002 Feb; 109(2):287-90.
Score: 0.004